Omalizumab
奥马珠单抗
Report date: 2026/05/25 20:02:40
First In Class
Base Information
Drug NameOmalizumab
Drug Alias Name +[20]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[33]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2002/01/01
Country/Territory +[32]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma AgGenentech Inc
China Registration ClassN/A
Develop Information
Active CompaniesChildren'S National Research InstituteStanford UniversityResearch Institute Of The Mcgill University Health Centre +[10]
Inactive CompaniesUtah State UniversityDana-Farber Cancer InstituteUniversity of Zurich +[25]
Active Indications +[11]
Inactive Indications +[22]